Development of WHO TCM Household Medicines Access Survey
To monitor the progress of efforts to improve the global medicines situation, WHO has developed a system
of indicators to measure important aspects of country pharmaceutical situations (see II.1). Level II
indicators measure key outcomes in the areas of access to medicines, product quality, and rational use of
medicines. These indicators can be used to assess progress over time; to compare situations across countries;
and to reassess and prioritize efforts based on the results. A pilot household survey to measure access to
and use of medicines by end-users was conducted in conjunction with the Level II health facility indicator
surveys between 2003 and 2004. Participants in a WHO Advisory Group Meeting held in Geneva in July 2006
including Dennis Ross-Degnan from the DPRG recommended revisions to the household survey for the next round
of Level II monitoring surveys.
In 2007, members of the CCPP collaborated with colleagues at WHO to revise the household survey instrument,
prepare a guide for its administration, create indicators of household access to and use of medicines, and
design an analysis tool with EpiData software to enter data and calculate indicators. During the field-testing
training workshops held in Jamaica (June 2007) and Nigeria (August 2007), Catherine Vialle-Valentin trained data
collectors on how to use the EpiData tools. An cross-country analysis of household survey date from 3 African
and 2 Caribbean countries will be prepared as soon as data collection is completed.
Annex 4 contains the current household survey instrument, the survey guide including indicators, and the slides
prepared for the Jamaica training. The Department of Technical Cooperation on Essential Drugs and Traditional
Medicines of WHO Geneva supports the household survey development.